Mangoceuticals Inc. (MGRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Mangoceuticals Inc.

    NASDAQ: MGRX · Real-Time Price · USD
    2.13
    -0.06 (-2.74%)
    At close: Sep 11, 2025, 3:59 PM
    2.11
    -0.94%
    After-hours: Sep 11, 2025, 06:15 PM EDT

    Mangoceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 615.87K 731.49K 8.94K n/a
    Cost of Revenue
    		 235.91K 299.99K 4.09K n/a
    Gross Profit
    		 379.96K 431.5K 4.85K n/a
    Operating Income
    		 -7.97M -9.22M -1.99M -17.52K
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -8.71M -9.21M -2M -70.8K
    Net Income
    		 -8.71M -9.21M -2M -17.7K
    Selling & General & Admin
    		 7.9M 8.55M 2M 17.52K
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 453.79K 1.1M n/a n/a
    Operating Expenses
    		 8.35M 9.65M 2M 17.52K
    Interest Expense
    		 13.7K n/a 6.47K 181.00
    Selling & Marketing Expenses
    		 1.48M 2.1M 352.86K n/a
    Cost & Expenses
    		 8.59M 9.95M 2M 17.52K
    Income Tax Expense
    		 n/a n/a n/a -70.08K
    Shares Outstanding (Basic)
    		 1.98M 1.07M 1.02M 997.67K
    Shares Outstanding (Diluted)
    		 1.98M 1.07M 1.02M 997.67K
    EPS (Basic)
    		 -4.84 -8.58 -1.96 -0.02
    EPS (Diluted)
    		 -4.84 -8.58 -1.96 -0.02
    EBITDA
    		 -7.96M -9.19M -1.99M 52.56K
    EBIT
    		 -8.69M -9.21M -1.99M -17.52K
    Depreciation & Amortization
    		 721.53K 24.89K 3.86K 70.08K

    Add to Watchlist